Cited by

• A NIK-IKKα module expands ErbB2-induced tumor-initiating cells by stimulating nuclear export of p27/Kip1.

  Zhang W, Tan W, Wu X, Poustovoitov M, Strasner A, Li W, Borcherding N, Ghassemian M, Karin M. Zhang W, et al. Cancer Cell. 2013 May 13;23(5):647-59. doi: 10.1016/j.ccr.2013.03.012. Epub 2013 Apr 18. Cancer Cell. 2013. PMID: 23602409 Free PMC article.
• p53 mutations and c-erbB-2 amplification in intraductal and invasive breast carcinomas of high histologic grade.

  Tsuda H, Iwaya K, Fukutomi T, Hirohashi S. Tsuda H, et al. Jpn J Cancer Res. 1993 Apr;84(4):394-401. doi: 10.1111/j.1349-7006.1993.tb00149.x. Jpn J Cancer Res. 1993. PMID: 8099903 Free PMC article.
• Detection of c-erbB-2 gene amplification in nipple discharge by means of polymerase chain reaction.

  Motomura K, Koyama H, Noguchi S, Inaji H, Azuma C. Motomura K, et al. Breast Cancer Res Treat. 1995;33(1):89-92. doi: 10.1007/BF00666075. Breast Cancer Res Treat. 1995. PMID: 7749137
• Synthetic phosphopeptide immunogens yield activation-specific antibodies to the c-erbB-2 receptor.

  Epstein RJ, Druker BJ, Roberts TM, Stiles CD. Epstein RJ, et al. Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10435-9. doi: 10.1073/pnas.89.21.10435. Proc Natl Acad Sci U S A. 1992. PMID: 1359539 Free PMC article.
• Transgenic oncogene mice. Tumor phenotype predicts genotype.

  Cardiff RD, Sinn E, Muller W, Leder P. Cardiff RD, et al. Am J Pathol. 1991 Sep;139(3):495-501. Am J Pathol. 1991. PMID: 1887859 Free PMC article.